{"transactions":[{"id":687847,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-13T20:15:19.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":36658,"price":3.499,"value":128266.342,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":505784,"source":{"system":"sec-edgar","filing":"0001140361-26-032818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126032818/form4.xml","form_type":"4"}},{"id":695462,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-06T00:49:40.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":101428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 101,428 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 3, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":101428,"derivative":{"exercise_price":3.41,"expiration_date":"2036-08-03","underlying":"Common Stock","underlying_shares":101428},"source":{"system":"sec-edgar","filing":"0001140361-26-031473","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126031473/form4.xml","form_type":"4"}},{"id":695461,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-06T00:49:40.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":73313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, one-third (1/3) of which will become fully vested on August 3, 2027, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":542442,"source":{"system":"sec-edgar","filing":"0001140361-26-031473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126031473/form4.xml","form_type":"4"}},{"id":904909,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T21:05:20.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":93037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 93,037 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":93037,"derivative":{"exercise_price":3.24,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":93037},"source":{"system":"sec-edgar","filing":"0001140361-26-005408","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005408/form4.xml","form_type":"4"}},{"id":904908,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-13T21:05:20.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":61963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":469129,"source":{"system":"sec-edgar","filing":"0001140361-26-005408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036126005408/form4.xml","form_type":"4"}},{"id":1073028,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-06T20:11:04.000Z","date":"2025-08-04","kind":"grant","planned":false,"acquired":true,"shares":554071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":554071,"derivative":{"exercise_price":3.07,"expiration_date":"2035-08-04","underlying":"Common Stock","underlying_shares":554071},"source":{"system":"sec-edgar","filing":"0001140361-25-029144","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125029144/form4.xml","form_type":"4"}},{"id":1073027,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":23675,"kind":"person","name":"Stevens Christopher James","position":1,"cik":"0002079768","reported_name":"Stevens Christopher James","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-08-06T20:11:04.000Z","date":"2025-08-04","kind":"grant","planned":false,"acquired":true,"shares":407166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"shares","element":"transactionShares","label":"F1","text":"Holdings are Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":407166,"source":{"system":"sec-edgar","filing":"0001140361-25-029144","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125029144/form4.xml","form_type":"4"}}]}